Table 4.
Core Data and Indications for Intervention.
| Patient | TAVI | Problem | SAVR | 30-Day Mortality |
|---|---|---|---|---|
| Patient 1 (m, 80Y) | TA-TAVI 26 mm Sapien XT |
Dislocation into left ventricular outflow tract | Single-stage 27 mm Hancock II |
no |
| Patient 2 (f, 78Y) | TF-TAVI 23 mm Sapien XT |
Annulus perforation | ≤7 days 21 mm PERIMOUNT |
no |
| Patient 3 (f, 76Y) | TF-TAVI 26 mm CoreValve |
Dislocation into ascending aorta | Single-stage 23 mm Hancock II circulatory arrest |
no |
| Patient 4 (m, 83Y) | TAO-TAVI 29 mm CoreValve |
Occlusion of the coronary left main trunk | Single-stage 21 mm Trifecta |
yes |
| Patient 5 (m, 65Y) | TAO-TAVI 34 mm CoreValve |
Paravalvular leakage | ≤7 days 25 mm Hancock II ECLS before SAVR |
yes |
| Patient 6 (f, 83Y) | TA-TAVI 26 mm Sapien 3 |
Annulus perforation with VSD | ≤7 days 21 mm Trifecta closure of VSD |
yes |
| Patient 7 (m, 85Y) | TAO-TAVI 29 mm CoreValve |
Endocarditis | >3 months 25 mm Hancock II |
no |
| Patient 8 (m, 78Y) | TF-TAVI 34 mm CoreValve |
Dislocation into LVOT | Single-stage 29 mm Hancock II ECLS after SAVR |
no |
| Patient 9 (f, 76Y) | TF-TAVI 25 mm Symetis |
Dislocation into ascending aorta | Single-stage 25 mm Hancock II circulatory arrest |
yes |
| Patient 10 (m, 83Y) | TA-TAVI 23 mm Sapien 3 |
Endocarditis | >3 months 21 mm Hancock II |
yes |
| Patient 11 (m, 79Y) | TF-TAVI 26 mm Sapien 3 |
Dislocation into aortic arch | Single-stage 23 mm PERIMOUNT circulatory arrest |
no |
f: Female, m: Male., SAVR: surgical aortic valve replacement, ECLS: Extracorporeal Life Support System